Selected article for: "oxygen therapy and supportive treatment"
Author: Nicola, Maria; O’Neill, Niamh; Sohrabi, Catrin; Khan, Mehdi; Agha, Maliha; Agha, Riaz
Title: Evidence Based Management Guideline for the COVID-19 Pandemic - Review article
  • Cord-id: ver7x3lx
  • Document date: 2020_4_11
    • ID: ver7x3lx
    Snippet: COVID-19 has now been declared a pandemic. To date, COVID-19 has affected over 944,181 people worldwide, resulting in over 47,312 reported deaths. Numerous preventative strategies and non-pharmaceutical interventions have been employed to mitigate the spread of disease including careful infection control, the isolation of patients, and social distancing. Management is predominantly focused on the provision of supportive care, with oxygen therapy representing the major treatment intervention. Med
    Document: COVID-19 has now been declared a pandemic. To date, COVID-19 has affected over 944,181 people worldwide, resulting in over 47,312 reported deaths. Numerous preventative strategies and non-pharmaceutical interventions have been employed to mitigate the spread of disease including careful infection control, the isolation of patients, and social distancing. Management is predominantly focused on the provision of supportive care, with oxygen therapy representing the major treatment intervention. Medical therapy involving corticosteroids and antivirals have also been encouraged as part of critical management schemes. However, there is at present no specific antiviral recommended for the treatment of COVID-19, and no vaccine is currently available. Despite the strategic implementation of these measures, the number of new reported cases continues to rise at a profoundly alarming rate. As new findings emerge, there is an urgent need for up-to-date management guidelines. In response to this call, we review what is currently known regarding the management of COVID-19, and offer an evidence-based review of current practice.

    Search related documents:
    Co phrase search for related documents
    • active case and acute management: 1, 2
    • active case and acute respiratory sari infection: 1
    • active case and acute sars cov respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • active case and lung involvement: 1, 2
    • acute aki kidney injury and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8
    • acute aki kidney injury and lung damage: 1, 2
    • acute aki kidney injury and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute management and long term disability: 1, 2
    • acute management and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7
    • acute management and low respiratory tract: 1
    • acute management and low tidal volume: 1, 2, 3, 4, 5, 6, 7
    • acute management and lung damage: 1, 2, 3, 4
    • acute management and lung include: 1
    • acute management and lung involvement: 1, 2
    • acute respiratory sari infection and lung damage: 1
    • acute respiratory sari infection and lung involvement: 1
    • acute sars cov respiratory syndrome coronavirus and liver finding: 1, 2
    • acute sars cov respiratory syndrome coronavirus and long term complication: 1, 2
    • acute sars cov respiratory syndrome coronavirus and long term disability: 1, 2